{
    "clinical_study": {
        "@rank": "21765", 
        "acronym": "PATH-BP", 
        "arm_group": [
            {
                "arm_group_label": "Paracetamol", 
                "arm_group_type": "Active Comparator", 
                "description": "paracetamol 1g (500mg x2) four times daily for 14 day period"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Matched placebo control: hard gelatin placebo capsules containing Lactose Ph Eur. Taken for 14 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine if chronic paracetamol dosing increases blood\n      pressure in patients with known high blood pressure."
        }, 
        "brief_title": "PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study", 
        "completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Blood Pressure", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "A prospective randomised, double-blind, crossover trial, comparing the effects of\n      paracetamol 1g (500mg x2) four times daily with matched placebo on ambulatory and clinic BP,\n      each given for 14 days, with a 14-day washout period."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u226518 years old, men or post-menopausal women (women with no periods for 12 months or\n             more, or those who have had a surgical menopause)\n\n          -  Treated hypertensive patients with an average daytime ambulatory blood pressure\n             measurement (ABPM) <150/95mmHg on stable doses of one or more antihypertensive\n             medication (at least one of which should be; an ACE inhibitor, angiotensin receptor\n             blocker or diuretic) for 3 months, or untreated hypertensive patients with an average\n             daytime ABPM \u2265135/85 but <150/95.\n\n        Exclusion Criteria:\n\n          -  History of ischaemic heart disease, cardiac failure, cerebrovascular disease, liver\n             impairment (ALT/AST>50IU/L) or stage 3-5 chronic kidney disease.\n\n          -  History of overdose or suicidal ideation\n\n          -  Patients weighing <55kgs.\n\n          -  Patients with chronic pain requiring treatment, with a known allergy to paracetamol,\n             or concomitant use of non-steroidal anti-inflammatories , oral anticoagulants or\n             corticosteroids."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997112", 
            "org_study_id": "PATHBP_2013", 
            "secondary_id": "PG/13/26/3012 8"
        }, 
        "intervention": {
            "arm_group_label": "Paracetamol", 
            "intervention_name": "Paracetamol", 
            "intervention_type": "Drug", 
            "other_name": "Acetaminophen"
        }, 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Blood pressure", 
            "Hypertension", 
            "Paracetamol", 
            "Acetaminophen"
        ], 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "contact": {
                "email": "iain.macintyre@nhs.net", 
                "last_name": "Iain M MacIntyre, MBChB", 
                "phone": "07789056966"
            }, 
            "contact_backup": {
                "email": "v.melville@ed.ac.uk", 
                "last_name": "Vanessa Melville", 
                "phone": "0131 537 2008"
            }, 
            "facility": {
                "address": {
                    "city": "Edinburgh", 
                    "country": "United Kingdom", 
                    "state": "City of Edinburgh", 
                    "zip": "EH4 2XU"
                }, 
                "name": "Clinical Research Centre, Western General Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Iain M MacIntyre, MBChB", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "David J Webb, MBChB", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study", 
        "overall_contact": {
            "email": "d.j.webb@ed.ac.uk", 
            "last_name": "David J Webb, MBChB", 
            "phone": "0131 242 9215"
        }, 
        "overall_contact_backup": {
            "email": "iain.macintyre@nhs.net", 
            "last_name": "Iain M MacIntyre, MBChB", 
            "phone": "07789056966"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Difference in mean daytime systolic ambulatory BP between the paracetamol and placebo treated groups.", 
            "measure": "Systolic ambulatory blood pressure", 
            "safety_issue": "No", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997112"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Difference in systolic clinic BP between the paracetamol and placebo treated groups.", 
                "measure": "Systolic clinic blood pressure", 
                "safety_issue": "No", 
                "time_frame": "14 days"
            }, 
            {
                "description": "Difference in mean daytime diastolic ambulatory BP between the paracetamol and placebo treated groups.", 
                "measure": "Diastolic ambulatory blood pressure", 
                "safety_issue": "No", 
                "time_frame": "14 days"
            }
        ], 
        "source": "University of Edinburgh", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "British Heart Foundation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Health Service, United Kingdom", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Edinburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}